Mounjaro and Depression: What the Research Suggests

GLP-1 receptor agonists like semaglutide (Wegovy) and the dual GIP/GLP-1 agonist tirzepatide (Mounjaro) act on appetite-regulating pathways in the brain. There is emerging interest among researchers in whether these pathways may also influence mood, motivation, and emotional wellbeing — though this is an active area of investigation rather than settled science.

What people commonly report

Some people taking weight-loss injections describe feeling less controlled by food cravings and report that reduced "food noise" has a positive effect on their mental state day to day. Others notice periods of low mood, fatigue, or emotional flatness, particularly in the earlier weeks of treatment or after a dose adjustment. Both experiences are reported, and neither is universal.

The official position on mental health side effects

The product information for both Mounjaro and Wegovy notes that mood and mental health changes are among the effects that should be monitored. If you experience new or worsening feelings of depression, anxiety, or any thoughts of self-harm while taking these medicines, contact your healthcare professional promptly — do not wait for your next scheduled appointment. These are classified as special-care topics that require direct clinical input.

People already living with depression or anxiety who are prescribed Mounjaro or Wegovy are not excluded from using these medicines, but their prescriber will have taken their full history into account. Any questions about whether the medicine is interacting with your mental health should go directly to the person who prescribed it to you.

For a broader overview of the medicine and its commonly reported effects, see our Mounjaro information hub. If you are specifically interested in how mood changes have been discussed alongside Mounjaro use, the page on Mounjaro and low mood explores this in more detail. Those exploring the differences and similarities between the two main GLP-1 options may also find the Wegovy and Mounjaro comparison a useful reference.

One practical step you can take right now is to log your mood consistently, so that if you do need to speak with your prescriber, you have a clear, dated record to share rather than relying on memory.

GLP Trackr includes a daily check-in that captures mood and energy levels alongside your dose, sleep, and other wellbeing markers each day. Over time, this builds a picture of how your mood shifts in relation to your injection schedule, dose changes, or other factors — the kind of pattern that can be genuinely useful to bring to a clinical conversation. The app also includes a doctor report feature, which lets you summarise your journey data in a format you can share at your next appointment.

If you notice any connection between your mood and other aspects of your GLP-1 journey — for instance, whether lower energy days cluster around injection day — the insights and correlations view in the app can help surface those patterns from your own data.

GLP Trackr is a tracking tool, not a clinical service. It does not assess, diagnose, or treat depression or any other condition. If you are concerned about your mental health, please contact your prescriber or doctor — they know your full history and are the right people to help. You can also explore how Mounjaro may interact with other aspects of health, such as the page on Mounjaro and endometriosis, which touches on mood-related hormonal factors some users raise.

Keeping a consistent daily log is one of the most useful things you can do to support those conversations. Download GLP Trackr on the App Store or Google Play and start your free 7-day trial — your mood tracking, dose log, and check-in history will all be there when you need them.